Your browser doesn't support javascript.
loading
Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
Delbos, Florent; Barhoumi, Walid; Cabanne, Ludovic; Beckerich, Florence; Robin, Christine; Redjoul, Rabah; Astati, Safae; Toma, Andréa; Pautas, Cécile; Ansart-Pirenne, Hélène; Cordonnier, Catherine; Bierling, Philippe; Maury, Sébastien.
Afiliación
  • Delbos F; Etablissement Français du Sang, Ile de France, HLA Laboratory, Créteil, France.
  • Barhoumi W; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Cabanne L; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Beckerich F; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Robin C; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Redjoul R; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Astati S; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Toma A; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Pautas C; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Ansart-Pirenne H; Etablissement Français du Sang, Ile de France, HLA Laboratory, Créteil, France.
  • Cordonnier C; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France.
  • Bierling P; Etablissement Français du Sang, Ile de France, HLA Laboratory, Créteil, France; IMRB, University Paris Est Créteil, INSERM U955, Créteil, France.
  • Maury S; Department of Hematology, AP-HP, Hôpital Henri Mondor, DHU Virus-Immunity-Cancer, Créteil, France; IMRB, University Paris Est Créteil, INSERM U955, Créteil, France; Center for Clinical Investigation in Biotherapy, Créteil, France. Electronic address: sebastien.maury@hmn.aphp.fr.
Biol Blood Marrow Transplant ; 22(2): 292-299, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26453972
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos HLA-D / Inmunización / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2016 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos HLA-D / Inmunización / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2016 Tipo del documento: Article País de afiliación: Francia